sofosbuvir


Also found in: Medical, Wikipedia.
Related to sofosbuvir: simeprevir, daclatasvir, ribavirin
Translations

sofosbuvir

n sofosbuvir m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Twelve week regimen of once daily daclatasvir plus sofosbuvir has showen good results in patients with HCV genotype 3 with sustained virological response of 91%.7 ALLY 3 phase III study also showed good virological response in genotype 3 treatment naive and treatment experienced patients.8 Treatment naive patients had 96% SVR rates as compared to treatment experienced patients (86%) with higher SVR rates in patients without cirrhosis.
The approval of Sofosbuvir, an NS5B polymerase inhibitor in 2013 by FDA was a breakthrough in the management of patients suffering from chronic HCV infection and is the backbone of current therapeutic regimen.
Viral hepatitis presentations include studies of Epclusa (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni (ledipasvir 90mg/sofosbuvir 400mg) in difficult to cure HCV populations and data demonstrating the role of Vemlidy (tenofovir alafenamide 25mg, TAF) in the management of chronic hepatitis B.
United States-based Gilead Sciences is planning to introduce authorised generic versions of Epclusa (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni (ledipasvir 90mg/sofosbuvir 400mg) in the United States, it was reported yesterday.
Enrolled subjects will self-administer orally 400 mg of CC-31244 and a fixed dose combination of sofosbuvir and velpatasvir for 14 days.
Thalia Medeiros, from the Universidade Federal Fluminense in Niteroi, Brazil, and colleagues evaluated renal biomarkers among 94 chronic hepatitis C patients treated with sofosbuvir therapy.
(7-11) Since 2015 three DAA options have been available in the Brazilian public health system: sofosbuvir, daclatasvir, and simeprevir.
Not only Daclatasavir pills but the provincial government had also bought Sofosbuvir the first anti-hepatitis C oral drug at Rs49 per tablet last year against its market price of over Rs100.
Sofosbuvir is another pangenotypic oral NS5B inhibitor with once-daily dosing that is both effective and tolerable.
Initially, only Sofosbuvir/Ribavirin combination was available in Indian market, so initially (2015) HCV genotype 1 infected patients were given Sofosbuvir 400 mg daily/weight based Ribavirin, adjusted for anaemia (n = 7).